Pioneering moment in Indian oncology as Marengo CIMS makes advanced, life-saving CAR-T therapy affordable and accessible for cancer patients
- Marengo CIMS Hospital Marks Breakthrough with First Successful CAR-T Cell Therapy in Gujarat
- Marengo CIMS Leads Gujarat’s Fight Against Cancer with First-Ever CAR-T Cell Therapy
- New Hope in Cancer Care: Marengo CIMS Performs Landmark CAR-T Therapy for Leukemia Patient
- Bringing Global Innovation Home: Marengo CIMS Introduces Affordable CAR-T Therapy in India
- Revolution in Oncology — Marengo CIMS Hospital Achieves Major Milestone with CAR-T Treatment Success
Bilkul Online | Ahmedabad | 07 Nov 2025
In a remarkable stride toward advancing cancer treatment in India, Marengo CIMS Hospital has successfully performed its first CAR-T (Chimeric Antigen Receptor T-cell) therapy on a patient suffering from relapsed B-cell Acute Lymphoblastic Leukemia (ALL). This marks a historic moment in the hospital’s ongoing mission to make world-class cancer care both accessible and affordable.
CAR-T therapy — one of the most revolutionary developments in modern oncology — involves genetically modifying a patient’s own immune cells (T-cells) to recognize and destroy cancer cells. While globally known for its high cost, Marengo CIMS Hospital has taken a crucial step in bringing this cutting-edge, life-saving therapy within the reach of Indian patients, especially those in Gujarat and neighbouring regions.
The therapy was administered under the leadership of Dr. Kaumil Patel, Consultant Hematologist, Hemato-Oncologist and BMT Physician, with vital support from Dr. Bhavesh Parekh, Head of Medical Oncology, and their dedicated teams.
“Performing the first CAR-T infusion at Marengo CIMS Hospital is not just a medical achievement; it is a step forward in making world-class cancer therapy accessible to patients who need it the most,” said Dr. Kaumil Patel. “Our team’s goal is to combine expertise, innovation, and compassion to give patients the best possible chance for recovery.”
The patient, who had relapsed after conventional treatments, has responded well to the therapy and remains under close observation by the hospital’s hematology and oncology teams. Explaining the significance of this advancement, Dr. R. Shankaran, Unit Medical Director, said, “CAR-T therapy is a game-changer in the field of hematologic cancers. It allows us to offer a personalized and highly effective treatment option that was previously out of reach for most patients due to cost and availability.”
Highlighting the institution’s broader vision, Dr. Keyur Parikh, Interventional Cardiologist and Chairman of Marengo CIMS Hospital, remarked, “At Marengo CIMS, we believe true healthcare excellence lies in bridging the gap between innovation and accessibility. The successful implementation of CAR-T therapy is not just a medical triumph but a promise — that world-class, life-saving treatments can and should be available to every patient, right here in India. This milestone reinforces our vision of placing India at the forefront of advanced and affordable healthcare.”
Echoing this sentiment, Dr. Raajiv Singhal, Founding Member, Managing Director & Group CEO, Marengo Asia Hospitals, added, “At Marengo Asia Hospitals, our commitment is clear—to deliver clinical excellence backed by advanced technology, expert teams, and a strong patient-first philosophy. The successful administration of CAR-T therapy is a reflection of our ability to bring global-standard treatments within reach of patients in India. We are not just treating disease; we are creating access to the most sophisticated therapies through world-class infrastructure, specialised talent, and outcome-driven care pathways.”
With this achievement, Marengo CIMS Hospital joins a select group of medical centres in Gujarat offering CAR-T therapy, establishing itself at the forefront of precision cancer treatment in India. The hospital aims to expand its CAR-T program to cover additional blood cancers, continuing its mission to make advanced therapies available locally and to reduce the emotional and financial strain on patients and their families.
This milestone underscores Marengo CIMS Hospital’s dedication to medical innovation, multidisciplinary collaboration, and patient-centric care, reaffirming its position as a leader in accessible, world-class oncology services.
Kindly Like the shared links and Subscribe our channel. https://youtube.com/shorts/5BH5iMFXydk?feature=share https://youtu.be/qVH_hGznkvc
